Beta Bionics, Inc. (BBNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q1 '24: 12.9M Q2 '24: 15M Q3 '24: 16.7M Q4 '24: 20.4M Q1 '25: 17.6M Q2 '25: 23.2M Q3 '25: 27.3M Q4 '25: 32.1M Q1 '26: 27.6M Q2 '26: 32M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q1 '24: 7.2M Q2 '24: 8.1M Q3 '24: 8.9M Q4 '24: 11.7M Q1 '25: 9M Q2 '25: 12.5M Q3 '25: 15.1M Q4 '25: 18.9M Q1 '26: 16.4M Q2 '26: 18.9M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q1 '24: -9.5M Q2 '24: -11.8M Q3 '24: -11M Q4 '24: -13M Q1 '25: -18.6M Q2 '25: -19.9M Q3 '25: -17M Q4 '25: -16.1M Q1 '26: -24.3M Q2 '26: -25.6M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income Quarterly

-30M -20M -10M 0 10M 20M 30M Q1 '24: -12.4M Q2 '24: -14.5M Q3 '24: -9.7M Q4 '24: -18.1M Q1 '25: -28.7M Q2 '25: -16.9M Q3 '25: -14.2M Q4 '25: -13.5M Q1 '26: -21.9M Q2 '26: -23.4M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue Quarterly

0 5M 10M 15M Q1 '24: 5.7M Q2 '24: 7M Q3 '24: 7.8M Q4 '24: 8.8M Q1 '25: 8.7M Q2 '25: 10.7M Q3 '25: 12.1M Q4 '25: 13.2M Q1 '26: 11.2M Q2 '26: 13.1M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-27M -18M -9M 0 9M 18M 27M Q1 '24: -12.1M Q2 '24: -12.2M Q3 '24: -9.6M Q4 '24: -14.3M Q1 '25: -20M Q2 '25: -13.6M Q3 '25: -8.7M Q4 '25: -8.6M Q1 '26: -23.8M Q2 '26: -14.6M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow Quarterly

-27M -18M -9M 0 9M 18M 27M Q1 '24: -12.6M Q2 '24: -12.7M Q3 '24: -11.5M Q4 '24: -14.8M Q1 '25: -20.3M Q2 '25: -15.4M Q3 '25: -10M Q4 '25: -10.5M Q1 '26: -25.2M Q2 '26: -15.7M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 6M Q2 '24: 6.1M Q3 '24: 6.7M Q1 '25: 30.7M Q2 '25: 43.4M Q3 '25: 43.6M Q1 '26: 44.4M Q2 '26: 44.5M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '24: -8.64 Q1 '25: -7.50 Q2 '25: -5.52 Q3 '25: -4.39 Q4 '25: -1.94 Q1 '26: -1.50 Q2 '26: -1.64 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.